Literature DB >> 8742477

Reactive astrocytes express substance-P immunoreactivity in the adult forebrain after injury.

R C Lin1.   

Abstract

Transformation of normal resting astrocytes to reactive astrocytes after injury is a well-known phenomenon. Using immunofluorescent labelling methods, astrocytes in the ischemically and retrogradely/anterogradely damaged adult forebrain nuclei were shown to express substance-P immunoreactivity. In contrast, astrocytes were not immunostained for substance-P in the normal brain or undamaged areas. Since substance-P has been shown to regulate inflammatory, wound-healing and immune responses in the peripheral tissues, it is likely that this aberrant expression of substance-P immunoreactivity in reactive astrocytes may relate to similar functions in the central nervous system as in the peripheral tissues after injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8742477

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

2.  A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.

Authors:  P G Kennedy; J Rodgers; F W Jennings; M Murray; S E Leeman; J M Burke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 3.  Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury.

Authors:  Robert Vink; Corinna van den Heuvel
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

4.  Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.

Authors:  W-W Li; T-Z Guo; X Shi; Y Sun; T Wei; D J Clark; W S Kingery
Journal:  Neuroscience       Date:  2015-09-16       Impact factor: 3.590

5.  Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.

Authors:  Jing Yu; Jing Wang; Jean Lud Cadet; Jesus A Angulo
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

Review 6.  Biomarkers of cognitive dysfunction in traumatic brain injury.

Authors:  Zhao-Liang Sun; Dong-Fu Feng
Journal:  J Neural Transm (Vienna)       Date:  2013-08-14       Impact factor: 3.575

7.  Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.

Authors:  Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

Review 8.  Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation.

Authors:  Frances Corrigan; Kimberley A Mander; Anna V Leonard; Robert Vink
Journal:  J Neuroinflammation       Date:  2016-10-11       Impact factor: 8.322

9.  Anti-allodynic effect of interleukin 10 in a mouse model of complex regional pain syndrome through reduction of NK1 receptor expression of microglia in the spinal cord.

Authors:  Jong-Heon Kim; Jin-Sung Park; Donghwi Park
Journal:  J Pain Res       Date:  2018-09-04       Impact factor: 3.133

10.  Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.

Authors:  Elizabeth Harford-Wright; Kate M Lewis; Mounir N Ghabriel; Robert Vink
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.